Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV
Clinical trial NCT05122026 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05122026
- Sponsor
- The Aurum Institute NPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-17
- Primary completion
- 2025-10-24
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.